Komplementsystem und Komplementdefekte

Por Kirschfink, Michael
Publicado no Pädiatrie (2014)

Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention

Por Fishelson, Zvi, Kirschfink, Michael
Publicado no Front Immunol (2019)

Modern Complement Analysis

Por Kirschfink, Michael, Mollnes, Tom E.
Publicado em 2003

Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement‐dependent anti‐tumor activity of trastuzumab and pertuzumab

Por Mamidi, Srinivas, Cinci, Marc, Hasmann, Max, Fehring, Volker, Kirschfink, Michael
Publicado no Mol Oncol (2013)

Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection

Por Protzer, Ulrike, Nassal, Michael, Chiang, Pei-Wen, Kirschfink, Michael, Schaller, Heinz
Publicado em 1999

Interactive film scenes for tutor training in problem-based learning (PBL): dealing with difficult situations

Por Bosse, Hans M, Huwendiek, Soeren, Skelin, Silvia, Kirschfink, Michael, Nikendei, Christoph
Publicado em 2010

Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells

Por Mamidi, Srinivas, Höne, Simon, Teufel, Claudia, Sellner, Leopold, Zenz, Thorsten, Kirschfink, Michael
Publicado no Oncoimmunology (2015)

Increased compensatory kidney workload results in cellular damage in a short time porcine model of mixed acidemia – Is acidemia a ‘first hit’ in acute kidney injury?

Por Russ, Martin, Ott, Sascha, Bedarf, Janis R., Kirschfink, Michael, Hiebl, Bernhard, Unger, Juliane K.
Publicado no PLoS One (2019)

Developing medical educators – a mixed method evaluation of a teaching education program

Por Roos, Marco, Kadmon, Martina, Kirschfink, Michael, Koch, Eginhard, Jünger, Jana, Strittmatter-Haubold, Veronika, Steiner, Thorsten
Publicado em 2014

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies

Por Münch, Johannes, Bachmann, Anette, Grohmann, Maik, Mayer, Christof, Kirschfink, Michael, Lindner, Tom H, Bergmann, Carsten, Halbritter, Jan
Publicado no Clin Kidney J (2017)

Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome: A Case Report

Por Kronbichler, Andreas, Frank, Renate, Kirschfink, Michael, Szilágyi, Ágnes, Csuka, Dorottya, Prohászka, Zoltán, Schratzberger, Peter, Lhotta, Karl, Mayer, Gert
Publicado no Medicine (Baltimore) (2014)

Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome

Por Mache, Christoph J., Acham-Roschitz, Birgit, Frémeaux-Bacchi, Veronique, Kirschfink, Michael, Zipfel, Peter F., Roedl, Siegfried, Vester, Udo, Ring, Ekkehard
Publicado em 2009

Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties

Por Röttgerding, Florian, Wagemakers, Alex, Koetsveld, Joris, Fingerle, Volker, Kirschfink, Michael, Hovius, Joppe W., Zipfel, Peter F., Wallich, Reinhard, Kraiczy, Peter
Publicado no Sci Rep (2017)

Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis

Por Chanchlani, Rahul, Thorner, Paul, Radhakrishnan, Seetha, Hebert, Diane, Langlois, Valerie, Arora, Steven, Barth, David, Cattran, Daniel, Kirschfink, Michael, Licht, Christoph
Publicado no Kidney Int Rep (2017)

Author Correction: Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties

Por Röttgerding, Florian, Wagemakers, Alex, Koetsveld, Joris, Fingerle, Volker, Kirschfink, Michael, Hovius, Joppe W., Zipfel, Peter F., Wallich, Reinhard, Kraiczy, Peter
Publicado no Sci Rep (2019)

A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma

Por Gallenkamp, Juliane, Spanier, Gerrit, Wörle, Elisabeth, Englbrecht, Markus, Kirschfink, Michael, Greslechner, Roman, Braun, Regine, Schäfer, Nicole, Bauer, Richard J., Pauly, Diana
Publicado no Oncotarget (2017)

Immunological Alterations due to Hemodialysis Might Interfere with Early Complications in Renal Transplantation

Por Mai, Kristin, Boldt, Andreas, Hau, Hans-Michael, Kirschfink, Michael, Schiekofer, Stephan, Keller, Frieder, Beige, Joachim, Giannis, Athanassios, Sack, Ulrich, Rasche, Franz Maximilian
Publicado no Anal Cell Pathol (Amst) (2019)

European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guide...

Por Brodszki, Nicholas, Frazer-Abel, Ashley, Grumach, Anete S., Kirschfink, Michael, Litzman, Jiri, Perez, Elena, Seppänen, Mikko R. J., Sullivan, Kathleen E., Jolles, Stephen
Publicado no J Clin Immunol (2020)

Identification and characterization of a unique role for EDB fibronectin in phagocytosis

Por Kraft, Sabrina, Klemis, Verena, Sens, Carla, Lenhard, Thorsten, Jacobi, Christian, Samstag, Yvonne, Wabnitz, Guido, Kirschfink, Michael, Wallich, Reinhard, Hänsch, G. Maria, Nakchbandi, Inaam A.
Publicado no J Mol Med (Berl) (2015)

Complement factor H–related hybrid protein deregulates complement in dense deposit disease

Por Chen, Qian, Wiesener, Michael, Eberhardt, Hannes U., Hartmann, Andrea, Uzonyi, Barbara, Kirschfink, Michael, Amann, Kerstin, Buettner, Maike, Goodship, Tim, Hugo, Christian, Skerka, Christine, Zipfel, Peter F.
Publicado em 2013